Aligos Therapeutics, Inc. Human Resources Contracts & Agreements
23 Contracts & Agreements
- Bonus & Incentive Agreements (9 contracts)
- Change of Control Agreements (1)
- Compensation Agreements (2)
- Consulting Agreements (2)
- Employment Agreements (8)
- Separation Agreements (1)
- Non-Employee Director Compensation Policy (Filed With SEC on August 6, 2024)
- Amendment to the Aligos Therapeutics, Inc. 2020 Incentive Award Plan (Filed With SEC on June 28, 2024)
- Separation and release agreement with Leonid Beigelman (Filed With SEC on March 12, 2024)
- Amended and Restated Employment Agreement, effective as of December 1, 2020, by and between the Company and Lesley Calhoun (Filed With SEC on March 12, 2024)
- Amended and Restated Employment Agreement, effective as of December 1, 2020, by and between the Company and Matthew McClure (Filed With SEC on March 12, 2024)
- Consulting agreement by and between Aligos Therapeutics, Inc. and Kathleen Glaub, dated June 17, 2021 (Filed With SEC on August 5, 2021)
- Consulting Agreement by and between Aligos Therapeutics, Inc. and Kathy Glaub, dated June 17, 2021 (Filed With SEC on June 28, 2021)
- Form of Change in Control and Severance Agreement (Filed With SEC on May 10, 2021)
- Employment Agreement by and between Aligos Therapeutics, Inc. and Julian Symons, D.Phil., effective as of May 14, 2019 (Filed With SEC on May 10, 2021)
- Amended and Restated Employment Agreement, effective as of February 10, 2021, by and between the Company and Lawrence M. Blatt (Filed With SEC on May 10, 2021)
- Amended and Restated Employment Agreement, effective as of February 10, 2021, by and between the Company and Leonid Beigelman (Filed With SEC on May 10, 2021)
- Non-Employee Director Compensation Program (Filed With SEC on October 9, 2020)
- Confirmatory Employment Letter by and between Aligos Therapeutics, Inc. and Lucinda Quan, J.D., dated May 14, 2019 (Filed With SEC on October 9, 2020)
- Employment Agreement by and between Aligos Therapeutics, Inc. and Leonid Beigelman, Ph.D., dated August 16, 2018 (Filed With SEC on October 9, 2020)
- Employment Agreement by and between Aligos Therapeutics, Inc. and Lawrence M. Blatt, Ph.D., dated August 16, 2018 (Filed With SEC on October 9, 2020)
- Form of Restricted Stock Unit Award Grant Notice under the 2020 Incentive Award Plan (Filed With SEC on October 9, 2020)
- Form of Restricted Stock Award Agreement under the 2020 Incentive Award Plan (Filed With SEC on October 9, 2020)
- Form of Stock Option Grant Notice and Stock Option Agreement under the 2020 Incentive Award Plan (Filed With SEC on October 9, 2020)
- 2020 Incentive Award Plan (Filed With SEC on October 9, 2020)
- Form of International Stock Option Grant Notice and Stock Option Agreement under 2018 Equity Incentive Plan, as amended (Filed With SEC on September 25, 2020)
- Form of Early Exercise Stock Option Grant Notice and Stock Option Agreement under 2018 Equity Incentive Plan, as amended (Filed With SEC on September 25, 2020)
- Form of Stock Option Grant Notice and Stock Option Agreement under 2018 Equity Incentive Plan, as amended (Filed With SEC on September 25, 2020)
- 2018 Equity Incentive Plan, as amended (Filed With SEC on September 25, 2020)
